Agios Pharmaceuticals (AGIO) Prepaid Assets (2012 - 2026)
Agios Pharmaceuticals (AGIO) reported Prepaid Assets of $46.6 million for Q1 2026, up 10.15% on a YoY basis from $42.3 million in Q1 2025, and up 5.57% quarter-over-quarter from $44.1 million in Q4 2025.
Agios Pharmaceuticals (AGIO) Prepaid Assets (2012 - 2026) Analysis & Trends
Agios Pharmaceuticals has reported Prepaid Assets for 15 years, with the latest figure at $46.6 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 10.15% year-over-year to $46.6 million; the trailing twelve-month figure through Mar 2026 stood at $46.6 million (up 10.15% YoY), and the FY2025 full-year result was $44.1 million, up 9.87% from the prior year.
- Prepaid Assets for Q1 2026 stood at $46.6 million, up from $44.1 million in the prior quarter.
- The five-year high for Prepaid Assets was $46.6 million in Q1 2026, with the low at $34.5 million in Q2 2024.
- Historically, Prepaid Assets has averaged $40.9 million across 5 years, with a median of $40.2 million in 2024.
- Annual changes were most pronounced in 2022 — Prepaid Assets soared 121.55% — and 2023, when it declined 17.37%.
- Agios Pharmaceuticals' Prepaid Assets stood at $39.0 million in 2022, then slipped by 10.1% to $35.0 million in 2023, then advanced by 14.69% to $40.2 million in 2024, then rose by 9.87% to $44.1 million in 2025, then rose by 5.57% to $46.6 million in 2026.
- The last three Prepaid Assets figures came in at $46.6 million (Q1 2026), $44.1 million (Q4 2025), and $43.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Agios Pharmaceuticals | 2.01 Bn | 2.01 Bn | 19.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46.59 Mn |
| Dec 31, 2025 | 44.13 Mn |
| Sep 30, 2025 | 43.19 Mn |
| Jun 30, 2025 | 44.69 Mn |
| Mar 31, 2025 | 42.29 Mn |
| Dec 31, 2024 | 40.17 Mn |
| Sep 30, 2024 | 39.89 Mn |
| Jun 30, 2024 | 34.54 Mn |
| Mar 31, 2024 | 39.11 Mn |
| Dec 31, 2023 | 35.02 Mn |
| Sep 30, 2023 | 38.41 Mn |
| Jun 30, 2023 | 36.75 Mn |
| Mar 31, 2023 | 39.30 Mn |
| Dec 31, 2022 | 38.96 Mn |
| Sep 30, 2022 | 46.49 Mn |
| Jun 30, 2022 | 42.34 Mn |
| Mar 31, 2022 | 43.23 Mn |
| Dec 31, 2021 | 39.84 Mn |
| Sep 30, 2021 | 32.24 Mn |
| Jun 30, 2021 | 21.44 Mn |